Alex Garner currently serves as the Director of R&D at Piramal Pharma Solutions, a position held since April 2024. Prior roles include Director of Formulation and Clinical Trial Manufacturing at both Avomeen and Element Materials Technology from August 2021 to April 2024. Alex has significant experience as a Pharmaceutical Development Scientist II and as a Scientist III at Mayne Pharma and Patheon, respectively. Academic credentials include a Master of Science in Chemistry and dual Bachelor degrees in Chemistry and History from East Carolina University. Alex's expertise spans pharmaceutical development, analytical methodology, and client interaction, with a strong emphasis on process improvement and regulatory compliance.